Navigation Links
Apex Continues Fighting Against Patents to Free Up Competition

TAIPEI, July 29, 2014 /PRNewswire/ -- Apex Medical Corporation (Apex, TWSE: 4106), a leading player in the Respiratory Therapy and Pressure Area Care sectors, announces that it is appealing the judgment of the Regional Court of Munich in Germany that found the headgear of certain mask models infringe a ResMed patent. Apex notes that it has initiated invalidity challenges against various ResMed patents in major countries. Apex further reiterates its continuous efforts in counterattacking against trivial and junk patents.

ResMed filed the lawsuit with the Regional Court of Munich in November 2013, a few months after Apex successfully terminated patent litigation brought by ResMed in the US. The patent at issue is relating to fastening portion such as Velcro used in the headgear. The Regional Court of Munich held that Apex's Wizard 210 and Wizard 220 headgears were covered by one European patent of ResMed. However, as early as December 2013, Apex has challenged the validity of the same ResMed patent before the European Patent Office. Apex thus will appeal the judgment entered by the Regional Court.

Apex notes that the judgment is limited to headgears of specific masks distributed in Germany and does not cover masks or any other respiratory therapy products. Also, Apex's new headgear design is ready to be offered to the customers. The Regional Court's judgment therefore has limited effect on Apex's global operation.

In addition, earlier this year Apex has initiated patent invalidity challenges against ResMed's other German and European patents that ResMed asserted in separate proceedings. Meanwhile, based on the evidence submitted by Apex, the patent agencies in the United States, Japan, and China are conducting independent review on the validity of several ResMed patents.

The Company reiterates its belief that invalid or junk patents not only harm fair competition but also obstruct patients' access to quality products. Apex thus will continue fighting against invalid or junk patents to ensure freedom to market and fair competition.

Apex stresses its goal of serving patients suffering from sleeping disorders with quality, effective as well as cost-saving CPAP products, and affirms its devotion to innovation and its commitment to the customers.

About Apex

Apex Medical is a leading manufacturer of its own brand of Respiratory Therapy products and distributes through an established network of international subsidiaries and partners in Europe, the United States, Asia and other international markets. Apex specializes in product development, engineering and marketing products with a dedicated and innovative team of industry professionals. Apex aims to be a global leader in the provision of high quality healthcare products, delivering tested, trialed and clinically evaluated devices while ensuring that its own technology and intellectual property meet the demands of the Respiratory Therapy market.


Jack Hsu
Vice President
Apex Medical
Tel: +886-2-22685568

SOURCE Apex Medical Corp.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe
2. Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%;
3. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
4. Chronic Use of Prescription Painkillers Continues Following Bariatric Surgery
5. 50 Years Old and Still Bounding Over the Counter: Klines Healthcare Practice Continues to Deliver Unmatched OTC Market Intelligence
6. LEXION Medical Continues to Receive Recognition for Innovative Technologies
7. Harlan Laboratories Continues Strategic Growth with Expansion of South European Services Facility
8. KemPharm Continues to Expand its Pain Therapy Pipeline with Discovery of KP606, a Novel Prodrug of Oxycodone
9. Device Sector Facing Medical Education Challenges as Industry Continues Expansion into Emerging Markets
10. Americas Obsession with New "Anti-Aging" Pill Continues
11. Emdeon Continues Focus on Patient-Centered Healthcare Solutions; Renews Chain Drug Consortium Contract for Multiple Pharmacy Solutions
Post Your Comments:
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/7/2017)... --  Provista, a proven leader in the supply ... power, today announced a new resource area on ... is the online home for case studies, articles on ... releases, slideshows and events. ... at their fingertips, viewers can also watch short videos ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):